RESUMEN
In 2017, a chikungunya outbreak in central Italy later evolved into a secondary cluster in southern Italy, providing evidence of disease emergence in new areas. Officials have taken action to raise awareness among clinicians and the general population, increase timely case detection, reduce mosquito breeding sites, and promote mosquito bite prevention.
Asunto(s)
Fiebre Chikungunya/epidemiología , Fiebre Chikungunya/transmisión , Virus Chikungunya , Brotes de Enfermedades , Fiebre Chikungunya/historia , Fiebre Chikungunya/virología , Transmisión de Enfermedad Infecciosa , Geografía , Historia del Siglo XXI , Humanos , Italia/epidemiología , Mosquitos Vectores/virologíaRESUMEN
Health impact assessment (HIA) is a multidisciplinary method aimed at assessing the health effects of policies, plans, and projects using quantitative, qualitative, and participatory techniques. In many European countries, such as in Italy, there is a lack of implementation of HIA procedures and it would be necessary to develop instruments and protocols in order to improve the specific skills of professionals involved in the assessment process. This article aims to describe the development and implementation of HIA guidelines, promoted by the Italian National Agency for Regional Health Services (AGENAS), in 4 Southern Italian regions. Public health search engine and institutional Web sites were consulted to collect international data existing in this field. Monthly workshops were then organized with regional representatives to discuss the scientific literature and to identify the guidelines' contents: source of data, stakeholders, screening- and scoping-phase checklist tools, priority areas, monitoring, and reporting plans. Four regions (Calabria, Campania, Puglia, and Sicilia) took part in the project. This article describes the methodology of development and implementation of HIA guidelines in the Italian context. The tools created to collect data and assess health consequences (such as screening and scoping grids) are reported. This project represents the first structured initiative proposed and supported by the Ministry of Health aiming to introduce HIA in Italy. HIA should be considered a priority in the public health agenda, as a fundamental instrument in helping decision makers to make choices about alternatives to prevent disease/injury and to actively promote health.
Asunto(s)
Guías como Asunto/normas , Evaluación del Impacto en la Salud/métodos , Salud Pública/métodos , Política de Salud/tendencias , Servicios de Salud/normas , Humanos , Italia , Salud Pública/normasRESUMEN
Se presentan dos pacientes de hanseniasis multibacilar (LL y BB), con terapia multidroga, que se trataron con rifampicina diaria y al instaurarle el régimen intermitente se les produjo una insuficiencia renal aguda. Un paciente requirió un breve tiempo de hemodiálisis; el otro superó la insuficiencia renal aguda con tratamiento médico conservador. Siendo la rifampicina un antibiótico de primera importancia en el tratamiento de la enfermedad de Hansen, se alerta sobre esta reacción adversa
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Lesión Renal Aguda/etiología , Hipersensibilidad a las Drogas/complicaciones , Rifampin/efectos adversos , Lesión Renal Aguda/inducido químicamente , Lepra/tratamiento farmacológico , Rifampin , Rifampin/toxicidadRESUMEN
Se presentan dos pacientes de hanseniasis multibacilar (LL y BB), con terapia multidroga, que se trataron con rifampicina diaria y al instaurarle el régimen intermitente se les produjo una insuficiencia renal aguda. Un paciente requirió un breve tiempo de hemodiálisis; el otro superó la insuficiencia renal aguda con tratamiento médico conservador. Siendo la rifampicina un antibiótico de primera importancia en el tratamiento de la enfermedad de Hansen, se alerta sobre esta reacción adversa (AU)